For the prevention of Bcl-2, Chen et al. were the first to utilize MSNs coated with G2 amine-terminated polyamidoamine dendrimers to simultaneously deliver doxorubicin and Bcl-2-targeted siRNA into MDR A2780/AD human ovarian cancer cells for enhanced chemotherapy efficacy [55]. This evidence concerns the gene BCL2 and ovarian carcinoma.